DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Innovision Limited — Awarding of order(s)/contract(s)-(Sub-para 4-Para B)

NSE 1 hr ago·3 Sept 2026, 12:12 pm

INNOVISION NSE

Innovision Limited has announced the receipt of new orders, falling under Sub-para 4-Para B of its business disclosure guidelines. This update signals that the company has successfully secured fresh contracts, which is a positive development for its operational pipeline.

For investors, this news is generally viewed as a green flag, as it indicates continued business activity and potential revenue growth. It suggests the company is actively bidding for and winning new projects, which can be a key driver for future earnings.

Going forward, market participants should monitor the total value of these new orders and their duration. Tracking how these new contracts integrate with the company's existing order book will provide a clearer picture of its short-term growth trajectory.